Skip to main content
3 Biotech logoLink to 3 Biotech
. 2019 Jan 3;9(1):28. doi: 10.1007/s13205-018-1563-x

Principles of gene editing techniques and applications in animal husbandry

Shengwang Jiang 1, Qingwu W Shen 2,
PMCID: PMC6318154  PMID: 30622866

Abstract

Gene editing techniques were developed chronologically, which include zinc finger nuclease, transcription activator-like effector nuclease and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas 9). In this review, the working principles of these techniques were first introduced, their advantages and disadvantages were then discussed, their application in animal husbandry were elaborated, and finally human concerns about gene editing were presented. Compared to the two former techniques, the third-generation gene editing technique CRISPR/Cas9 has higher targeting efficiency and accuracy, less off-target effect, lower cytotoxicity and lower costs for being easier for vector design and manipulation. Although some people may concern about social or ethical issues, the benefits of gene editing certainly overweigh its demerits. The three gene editing techniques have been successfully used to improve the production and quality of livestock products, animal fertility, resistance to diseases, and welfare in animal husbandry. With legislation and the development of gene editing technology per se, it anticipatable that gene editing will have a broader utilization and make our lives happier.

Keywords: Gene editing, ZFN, TALEN, CRISPR/Cas9

Introduction

Gene editing is a molecular technology developed to modify specific sites within the genome through gene deletions, insertions or conversions for the purpose of studying functionally unknown genes or conducting gene therapy. As modified genetic information is inherited to the offspring, gene editing is frequently employed to modify biological traits of organisms to establish new varieties or improve the economic return of agriculture and livestock production. Several gene editing techniques have been developed chronologically, which include zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas 9) (CRISPR/Cas9). All these techniques use a specific nuclease or nuclease complex to recognize and cleave DNA at specific target sites to achieve DNA knock out or replacement through DNA repair machinery. In this review, the principles of gene editing were introduced, the advantages and disadvantages of different editing techniques were discussed, and their applications in the field of animal husbandry was reviewed and prospected.

Principles of gene editing techniques

ZFN technique

ZFN technique is a first-generation gene editing technique that utilizes a fused nuclease comprising a zinc finger protein (ZFP) and a Fok I restriction endonuclease (Kim et al. 1996). ZFP recognizes and binds to a specific DNA sequence while the dimerized Fok I, which possesses endonuclease activity, cuts the recognized sequence, thereby resulting in a DNA double-strand break (DSB) (Davis and Stokoe 2010). The DSB is subsequently repaired through non-homologous end-joining (NHEJ) or homologous recombination (HR) (Heyer et al. 2010). During the repair process in cells, mutations such as gene deletions or insertions are introduced, thereby achieving the goal of gene editing.

Zinc fingers are eukaryotic protein motifs that facilitate specific interactions between proteins and nucleic acids or different proteins. Multiple zinc fingers that recognize and bind to specific DNA sequence are tandem arranged and form ZFPs (Klug 2010). Every zinc finger specifically recognizes three consecutive nucleotides (triplets) on a single DNA chain. For example, a ZFP consisting of three zinc fingers are named from the N-terminal to the C-terminal as Finger 1 (F1), Finger 2 (F2), and Finger 3 (F3). These fingers bind to the target DNA along the 3′–5′ direction. Each zinc finger consists of approximately 30 amino acid residues, of which the − 1, + 3, and + 6 residues bind to the three bases of a triplet, thereby forming a 9 bp recognition site. The Fok I domain connects with the C-terminal of ZFP. When the distance between the two Fok I domains on the two sides of the double-stranded DNA is 5–7 bp, the two Fok I domains form an active dimer and cut DNA (Fig. 1) (Xiao et al. 2011; Pavletich and Pabo 1991).

Fig. 1.

Fig. 1

The principle of ZFN technique (Xiao et al. 2011). A ZFN monomer (two monomers are illustrated in the opposite direction along the double strand DNA) is composed of a Fok I cleavage domain and a ZFP domain consisting of three zinc fingers. The ZFP domain binds to one strand of a double-stranded DNA. The N-terminal of ZFP corresponds to the 3′-terminal of the target DNA. The − 1, + 3, + 6 amino acid residue of each zinc finger recognizes three consecutive bases (a triplet) in the 3′ → 5′ direction to form a 9-bp recognition site. The Fok I cleavage domain connects with the C-terminal of the ZFP; when the two Fok I domains in the opposite direction are spaced by 5–7 bp, they form a dimer and perform the cleavage function

TALEN technique

TALEN is a second-generation gene editing technique. Similar to ZFN, the core components of TALEN are a DNA binding protein and a Fok I restriction endonuclease. The difference is that TALEN utilizes transcription activator-like effector (TALE) instead of ZFP to fuse with the Fok I restriction endonuclease. TALE recognizes and binds to a specific DNA sequence, whereas Fok I, which possesses endonuclease activity after dimerization, cuts the recognized DNA to make a double-strand break. The double-strand break induces DNA repair through non-homologous end-joining or homologous recombination, performing gene editing (Fig. 2).

Fig. 2.

Fig. 2

The principle of TALEN technology (Mao and Tao 2015). a RVDs of TALE protein target and bind to dsDNA, and Fok I cleaves dsDNA. b dsDNA breaks. c The broken dsDNA is repaired by NHEJ or HR

The TALE protein is a secreted protein derived from the plant bacterial pathogen Xanthomonas (Bonas et al. 1989). As its structure is similar to transcription factors, TALE proteins regulate endogenous gene expression in host plants, thereby rendering sensitivity to infections (Bonas et al. 1989; Boch et al. 2009; Boch and Bonas 2010; Moscou and Bogdanove 2009). TALE proteins comprise three components: an N-terminal sequence for signal transduction, a tandem repeat sequence, and a C-terminal sequence that contains a nuclear localization signal and transcription activation domain (Boch et al. 2009). The tandem repeat sequence contains 12–33 repeat elements. Each repeat element is a sequence of 34 amino acid residues, of which the 12th and 13th amino acid residues are highly variable and referred to as repeat-variable di-residues (RVDs), but the rest residues are relatively conserved (Boch and Bonas 2010). RVDs determine the specificity of TALEs and are critical for targeting DNA. There are four common RVDs, which are NI (Asn–Ile), NG (Asn–Gly), HD (His–Asp), and NN (Asn–Asn). Each of the four RVDs has a fixed correspondence with A, T, C, or G. That is, NI identifies A, NG identifies T, HD identifies C, and NN identifies G (Boch et al. 2009; Boch and Bonas 2010; Moscou and Bogdanove 2009).

CRISPR/Cas9 system

CRISPR/Cas9 is a third-generation gene editing technique that involves artificially engineered immune system of bacteria and archaea, which mediates exogenous DNA degradation and therefore serves as a defense mechanism against viral infections (Boch and Bonas 2010; Bolotin et al. 2005; Pourcel et al. 2005; Mojica et al. 2005). The clustered regularly interspaced short palindromic repeats (CRISPR) were first discovered in the genome of E. coli in 1987 (Ishino et al. 1987), but did not arouse attention until 2012 when it was reported that CRISPR and the CRISPR-associated protein Cas9 cut DNA duplex at specific sites in vitro (Jinek et al. 2012). This finding potentiated the application of CRISPR/Cas9 in gene editing. 1 year later, Cong et al. (2013) designed two CRISPR/Cas9 systems and demonstrated that Cas9 nucleases could be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. This is a breakthrough in gene editing research.

CRISPR comprises a leader sequence, several repeat sequences and several spacer sequences (Makarova et al. 2006; Jarman et al. 1993; Wei et al. 2015). The leader sequence is located upstream of the CRISPR gene cluster. It has no coding activity, but serves as a species-specific promoter. The repeat sequences are highly conserved palindromic sequences that can form hairpin structures. The repeat sequences are not tandem arranged but interrupted by spacer sequences. The spacer sequences are homologous to some sequences in the genome of phages or plasmids, which enables the cells to recognize and defend against the invasion of these corresponding phages or plasmids (Stern et al. 2010). Cas9 nuclease complexes comprised of a Cas9 protein, a specific CRISPR RNA (crRNA), and a transactivation CRISPR RNA (tracrRNA). The crRNA and tracrRNA form a dimer and bind to the Cas9 protein. The complex recognizes and cuts target DNA at specific sites to generate double-strand breaks that induce DNA repair in cells. In the absence of homologous DNA, repair occurs through NHEJ, which facilitates gene deletion (Ma et al. 2014). When homologous DNA is present, repair occurs through HR, which facilitates gene insertion (Fig. 3).

Fig. 3.

Fig. 3

The principle of the CRISPR/Cas9 system (Mao and Tao 2015). The transcribed pre-crRNA is processed by Cas 9 protein and RNase III to a mature crRNA. The mature crRNA, Cas 9 and the transcribed tracrRNA bind together to form a complex. The complex recognizes and opens the target DNA sequence which is complementary to the crRNA. The crRNA hybridizes with the complementary DNA strand. Subsequently, the HNH activity site of the Cas9 protein cleaves the complementary DNA strand and the RuvC activity site cuts the other free DNA strand to form a DNA double-strand break. When protospacer adjacent motifs (PAMs) are present, HR or NHEJ mechanism is initiated to perform editing of the target gene

Advantages and disadvantages of different gene editing techniques

Compared to traditional HR, the ZFN technology has substantially high gene targeting efficiency (10–30%) (Table 1). ZFN technique does not require the use of embryonic stem cells and can be applied to various eukaryotic cells. ZFN is a first-generation gene editing technique and thus the most well established. However, the ZFN recognition domain is context-dependent. Its constituent amino acid repeats interact with each other, reducing the specificity and efficiency of gene targeting (Sander et al. 2011). In fact, it is difficult to design a suitable ZFN for any target gene. In another word, not all genes in the genome can be edited by ZFN. Besides, the ZFN technique has off-target effects, which in turn induces cytotoxicity (Sung et al. 2014).

Table 1.

Comparison of the three gene editing techniques

Gene editing technique Generation DNA recognition domain Endonuclease Advantages Disadvantages
ZFN First ZFP Fok I Targeting efficiency usually 10–30% (Fujii et al. 2013, 2015; Liu et al. 2015; Lei et al. 2012); most well-established Context-dependent; off-target effects; high cytotoxicity; complication in design
TALEN Second TALE Fok I Targeting efficiency usually 20–60%, high to 90% reported (Lei et al. 2012; Tesson et al. 2011; Jin et al. 2018; Nerys-Junior et al. 2018; Ding et al. 2013); not context dependent; little off-target effect; low cytotoxicity; easy to design; high specificity Complicated TALE molecular module assembly; requires extensive sequencing; high cost; difficult to operate
CRISPR/Cas9 Third crRNA Cas9 Targeting efficiency usually 50–80% (Ding et al. 2013; Nerys-Junior et al. 2018; Sugano et al. 2018); easy to design and operate; low cost; little off-target effect; low cytotoxicity Not well established; Cas9 cannot cut target sequence if no PAM exists

Compared to the ZFN technique, the TALEN approach has even higher targeting efficiency (20–60%) (Table 1). This technique also has higher specificity with little off-target effect and low cytotoxicity. In addition, it is easier to design a pair of TALENs than ZFNs for a specific target DNA sequence. However, the assembly of TALE molecular modules is complicated and requires extensive sequencing, which in turn increases cost. The molecular weight of TALE proteins is higher than that of ZFP proteins, which makes it more difficult to operate at the molecular level, albeit its capability in targeting longer gene sequences (Wright et al. 2014).

The CRISPR/Cas9 system has the highest targeting efficiency among the three techniques (50–80%) (Table 1). The construction of the CRISPR/Cas9 system mainly involves the design of a RNA sequence that is complementary to the target DNA sequence. Compared to ZFN and TALEN, CRISPR/Cas9 is easier for target site design, vector construction and operation, and has lower cost. Both ZFN and TALEN techniques target DNA by proteins, whereas the CRISPR/Cas9 system targets DNA through a base pairing mechanism using RNA. Therefore, DNA recognition by the CRISPR/Cas9 system is more accurate, with less off-target effect and lower cytotoxicity. However, this technology has been developed much later and is still in development. It may cause additional mutations in sites other than the target site (Ding et al. 2013; Fu et al. 2013). In addition, cutting of the target sequence depends not only on the matched crRNA sequence, but also on a few small PAMs. The Cas9 protein does not cut the target sequence if no PAM exists around the target sequence.

Applications of gene editing techniques in animal husbandry

To increase the production of livestock products

Myostatin (MSTN) negatively regulates muscle growth and development. Loss of MSTN function leads to the “double-muscle” trait. Using the ZFN technique, Qian et al. edited the MSTN gene in fibroblasts derived from Meishan pig fetuses. Through somatic cell nuclear transplantation, MSTN-mutated Meishan pigs were generated. Compared to the wild-type, MSTN mutated Meishan pigs have 11.62% higher lean meat production (Qian et al. 2015).

In addition, Yu et al. designed and transfected a pair of TALENs into goat fibroblasts, and obtained 272 monoclonal cells with MSTN gene mutations. Among these monoclonal cells, ten clones with different genotypes were used as donors for somatic cell nuclear transplantation, and three goat clones were obtained (K179/MSTN−/−, K52-2/MSTN+/−, and K52-1/MSTN+/+). The goat with the mutated MSTN gene exhibited significantly higher meat yield. Compared to the wild-type (K52-1/MSTN+/+), the double knockout goat clone (K179/MSTN−/−) had 1.7-fold higher body weight while the single knockout goat clone (K179/MSTN+/−) was 32% heavier than the wild-type (Yu et al. 2016). In addition, gene editing techniques have been employed in some other farm animal species to generate MSTN mutant animals with the aim to promote muscle development or to increase meat production (Wang et al. 2016b; Proudfoot et al. 2015; Luo et al. 2014; Li et al. 2016; Crispo et al. 2015).

Fibroblast growth factor 5 (FGF-5) is a regulatory factor that regulates hair growth. It converts hair follicles from the growing phase to the recessive phase. Mutation of FGF5 gene prolongs the growing phase and thus increases hair length. Using the CRISPR/Cas9 technique, Wang et al. microinjected MSTN- and FGF5-targeting vector Cas9 mRNA and sgRNAs into cashmere goat embryos and evaluated the top three economic traits in cashmere goat, including cashmere yield, cashmere fiber diameter and length. Results showed that the GFG5 mutated cashmere goats had significantly longer cashmere fibers and higher cashmere yield (Wang et al. 2016a).

To improve animal fertility and disease resistance

Porcine reproductive and respiratory syndrome (PRRS), also known as blue-ear pig disease, is a challenging disease for worldwide pig production. It causes severe breathing problems in young pigs and breeding failures in pregnant females. In addition, it brings about abortions, early farrowing, increased number of stillborn piglets, and weak neonatal piglets. PRRS virus targets macrophages. CD163 is a molecule on the surface of macrophages and plays a key role in enabling the PRRS virus to establish an infection. Burkard et al. used CRISPR/Cas9 to delete a small sequence of the CD163 gene in the pigs’ genome and generated 32 gene edited pigs. These pigs are resistant to infection when exposed to the PRRS virus. Only the sequence of CD163 that interacts with the PRRS virus was removed, so the CD163 proteins retains its other biological functions (Burkard et al. 2017).

Tuberculosis is a zoonotic disease and a leading health problem worldwide which accounts for about 1.5 million deaths annually (Gandhi et al. 2016). Bovine tuberculosis is a big threat to animal husbandry as no effective strategy is currently available to eliminate or control this disease. Expression of the mouse Sp110 nuclear body protein (Sp110) enhances macrophage apoptosis in response to Mycobacterium tuberculosis (Mtb) infection and upregulates host immunity to Mtb, providing a promising way to control Mtb growth and transmission. Wu et al. successfully utilized TALEN technology to insert a mouse SP110 gene into the genome of Holstein–Friesian cattle. Transgenic cattle with SP110 gene knock in showed increased resistance to Mtb infection (Wu et al. 2015).

To improve the quality of livestock products

Cows’ milk is rich in nutrients and serves as an ideal alternative milk source for infants other than breast milk. However, as the digestive system of infants is not well developed, the undigested β-lactoglobulin (BLG) in cows’ milk can be absorbed and recognized by the infants’ immune system as a pathogen, resulting in milk allergy. A BLG gene knockout cow was fist generated by Yu et al. (2011) using the ZFN technique to reduce BLG antigenicity and immunogenicity. For the same purpose, Zhou et al. co-injected Cas9 mRNA and small guide RNAs (sgRNAs) into goat embryos and successfully generated BLG knock-out goats (2017), which had significantly lower expression of BLG in mammary glands when compared to that of the wild-type goats. These studies provide a method to improve the quality of milk as well as to reduce milk allergies.

Eating foods rich in n-3 polyunsaturated fatty acids (n-3PUFAs) can effectively reduce the incidence of cardiovascular and cerebrovascular diseases. The fat-1 gene from Caenorhabditis elegans encodes a fatty acid desaturase which converts n-6 polyunsaturated fatty acids (n-6PUFAs) to n-3PUFAs when expressed within animal body. Thus, it is anticipated that fat-1 animals could be used to produce n-3PUFAs. For this end, Li et al. (2018) tried to insert the fat-1 gene from C. elegans into porcine Rosa 26 (pRosa26) locus via the CRISPR/Cas9 system and successfully generate fat-1 knock-in pigs. Gas chromatography analysis confirmed the expression of this gene in pig tissues as that fat-1 knock-in pigs exhibited a significantly increased level of n-3PUFAs, as well as an obviously decreased n-6PUFAs/n-3PUFAs ratio. These fat-1 transgenic pigs provide promise for improving the nutritional value of porcine products and serving as an animal model to investigate therapeutic effects of n-3PUFAs on diseases. Even better, Zhang et al. (2018) inserted the fat-1 gene into the goat MSTN locus using the CRISPR/Cas9 system to achieve simultaneous editing of the two genes. PCR and sequencing showed that the efficiency for simultaneous MSTN knockout and fat-1 knock-in was as high as 25.56%, demonstrating that the CRISPR/Cas9 system is a potential gene engineering tool in safe animal breeding.

To improve animal welfare

For the safety of the milkers and other animals, cows’ horns are commonly cut of shortly after birth. Cutting cows’ horns with an electric saw or burn off of cows’ horns with a soldering iron is not only painful to the animal, but also difficult to manipulate. The CRISPR/Cas9 has ever been introduced to knockout genes responsible for angular growth of cattle. With the combined use of in vitro fertilization and embryo transfer techniques, two hornless Holstein dairy cattle have been bred to avoid the painful horn cutting to improve animal welfare (Carlson et al. 2016).

Applications of gene editing techniques in other fields

In addition to the various applications in animal husbandry, gene editing techniques have been more commonly employed in biomedical research and gene therapy for human diseases (Soldner et al. 2011; Qiu et al. 2013; Xu et al. 2017). As for plants, gene editing has been frequently performed to improve crop resistance to herbicides or insects, to improve plant growth property, agri-product yield or quality (Shukla et al. 2009; Townsend et al. 2009; Ricroch and Henard-Damave 2016; Zhang et al. 2017; Li et al. 2012).

Concerns and prospect

As the genomes of more species have been sequencing, identification of gene function has become the research focus and task for the post-genome era. Gene editing technology can be used not only for gene therapy in which a mutated gene is replaced by a wild-type gene, but also for animal model development, animal trait improvement, and gene function studies in which a wild-type gene is replaced by a mutated gene. The ZFN, TALEN, and CRISPR/Cas9 gene editing techniques have been successfully employed in these areas. The ZFN technique was rated by the American magazine “Wired” as one of the top ten scientific breakthroughs in 2008. The TALEN technique and the CRISPR/Cas9 system were rated by the journal “Science” as one of the top ten scientific breakthroughs in 2012 and 2013, respectively.

Compared to conventional gene targeting techniques, gene editing does not require the use of embryonic stem cells, is applicable to more species, more accurate and more efficient. However, these gene editing techniques are not faultless. The off-target effect, complication in vector construction and high cost are the common problems. Despite these issues, gene editing will continue to be a powerful gene engineering tool as the technique per se will be keeping improved with the advances of molecular biology. For example, the targeting accuracy of CRISPR/Cas9 has been improved recently with the introduction of mutation (N692A/M694A/Q695A/H698A) in the REC3 domain (Chen et al. 2017). It is anticipatable that gene editing technique itself will once again have a revolutionary breakthrough to better benefit our lives and the world.

On the other side, concerns about gene editing have appeared (Ruan et al. 2017; Ledford 2017; Gaind 2016). These include food safety, ethical issues and social equity. First, the general public is not so familiar with gene editing and worries that this technology may have a negative impact on gene-edited organisms. In addition, they concern that it is unsafe to eat the products of gene-edited organisms as the pros and cons of gene editing have not been fully assessed (Ruan et al. 2017; Ledford 2017). Second, some people argue that using gene-editing techniques to improve or create species violates natural laws of survival and ethics (Gaind 2016). Finally, some people worry that this technology may become a privilege of the wealthy, with which only the rich people afford to replace their diseased organs or to knock-out their “harmful” genes, thus bringing about social inequity and even social unrest (Gaind 2016). For all these concerns, laws and regulations should be made to ensure the safety and equity of gene editing. In fact, it is not a matter of the technology per se, but a matter of humans how people use it. With the development of science and technology, we believe that this technology will make the world and our lives better and happier.

Acknowledgements

This work was supported by National Natural Science Foundation of China (Grant number 31571862).

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

References

  1. Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Ann Rev Phytopathol. 2010;48:419–436. doi: 10.1146/annurev-phyto-080508-081936. [DOI] [PubMed] [Google Scholar]
  2. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009;326(5959):1509–1512. doi: 10.1126/science.1178811. [DOI] [PubMed] [Google Scholar]
  3. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology. 2005;151(Pt 8):2551–2561. doi: 10.1099/mic.0.28048-0. [DOI] [PubMed] [Google Scholar]
  4. Bonas U, Stall RE, Staskawicz B. Genetic and structural characterization of the avirulence gene avrBs3 from Xanthomonas campestris pv. vesicatoria. Mol Gen Genetics MGG. 1989;218(1):127–136. doi: 10.1007/BF00330575. [DOI] [PubMed] [Google Scholar]
  5. Burkard C, Lillico SG, Reid E, Jackson B, Mileham AJ, Ait-Ali T, Whitelaw CB, Archibald AL. Precision engineering for PRRSV resistance in pigs: macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathogens. 2017;13(2):e1006206. doi: 10.1371/journal.ppat.1006206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carlson DF, Lancto CA, Zang B, Kim ES, Walton M, Oldeschulte D, Seabury C, Sonstegard TS, Fahrenkrug SC. Production of hornless dairy cattle from genome-edited cell lines. Nat Biotechnol. 2016;34(5):479–481. doi: 10.1038/nbt.3560. [DOI] [PubMed] [Google Scholar]
  7. Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature. 2017;550(7676):407–410. doi: 10.1038/nature24268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823. doi: 10.1126/science.1231143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crispo M, Mulet AP, Tesson L, Barrera N, Cuadro F, dos Santos-Neto PC, Nguyen TH, Creneguy A, Brusselle L, Anegon I, Menchaca A. Efficient generation of myostatin knock-out sheep using CRISPR/Cas9 technology and microinjection into zygotes. PloS One. 2015;10(8):e0136690. doi: 10.1371/journal.pone.0136690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davis D, Stokoe D. Zinc finger nucleases as tools to understand and treat human diseases. BMC Med. 2010;8:42. doi: 10.1186/1741-7015-8-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell. 2013;12(4):393–394. doi: 10.1016/j.stem.2013.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31(9):822–826. doi: 10.1038/nbt.2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fujii W, Kano K, Sugiura K, Naito K. Repeatable construction method for engineered zinc finger nuclease based on overlap extension PCR and TA-cloning. PloS One. 2013;8(3):e59801. doi: 10.1371/journal.pone.0059801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fujii W, Onuma A, Yoshioka S, Nagashima K, Sugiura K, Naito K. Finding of a highly efficient ZFN pair for Aqpep gene functioning in murine zygotes. J Reprod Dev. 2015;61(6):589–593. doi: 10.1262/jrd.2015-087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gaind N. Brain implants and gene-editing enhancements worry US public. Nature. 2016 doi: 10.1038/nature.2016.20350. [DOI] [Google Scholar]
  16. Gandhi PT, Athmaram TN, Arunkumar GR. Novel nicotine analogues with potential anti-mycobacterial activity. Bioorg Med Chem. 2016;24(8):1637–1647. doi: 10.1016/j.bmc.2016.02.035. [DOI] [PubMed] [Google Scholar]
  17. Heyer WD, Ehmsen KT, Liu J. Regulation of homologous recombination in eukaryotes. Ann Rev Genetics. 2010;44:113–139. doi: 10.1146/annurev-genet-051710-150955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987;169(12):5429–5433. doi: 10.1128/jb.169.12.5429-5433.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jarman AP, Grau Y, Jan LY, Jan YN. atonal is a proneural gene that directs chordotonal organ formation in the Drosophila peripheral nervous system. Cell. 1993;73(7):1307–1321. doi: 10.1016/0092-8674(93)90358-W. [DOI] [PubMed] [Google Scholar]
  20. Jin L, Deng Y, He N, Wang L, Weng M. Polyethylenimine-mediated CCR5 gene knockout using transcription activator-like effector nucleases. J Biomed Nanotechnol. 2018;14(3):546–552. doi: 10.1166/jbn.2018.2545. [DOI] [PubMed] [Google Scholar]
  21. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821. doi: 10.1126/science.1225829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA. 1996;93(3):1156–1160. doi: 10.1073/pnas.93.3.1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Klug A. The discovery of zinc fingers and their development for practical applications in gene regulation and genome manipulation. Quart Rev Biophys. 2010;43(1):1–21. doi: 10.1017/s0033583510000089. [DOI] [PubMed] [Google Scholar]
  24. Ledford H. Gene-edited cows, rogue clinics, speedier drug approvals: the challenges facing Trump’s FDA chief. Nature. 2017;541(7636):146–147. doi: 10.1038/nature.2017.21256. [DOI] [PubMed] [Google Scholar]
  25. Lei Y, Guo X, Liu Y, Cao Y, Deng Y, Chen X, Cheng CH, Dawid IB, Chen Y, Zhao H. Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs) Proc Natl Acad Sci USA. 2012;109(43):17484–17489. doi: 10.1073/pnas.1215421109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Li T, Liu B, Spalding MH, Weeks DP, Yang B. High-efficiency TALEN-based gene editing produces disease-resistant rice. Nat Biotechnol. 2012;30(5):390–392. doi: 10.1038/nbt.2199. [DOI] [PubMed] [Google Scholar]
  27. Li H, Wang G, Hao Z, Zhang G, Qing Y, Liu S, Qing L, Pan W, Chen L, Liu G, Zhao R, Jia B, Zeng L, Guo J, Zhao L, Zhao H, Lv C, Xu K, Cheng W, Li H, Zhao HY, Wang W, Wei HJ. Generation of biallelic knock-out sheep via gene-editing and somatic cell nuclear transfer. Sci Rep. 2016;6:33675. doi: 10.1038/srep33675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Li M, Ouyang H, Yuan H, Li J, Xie Z, Wang K, Yu T, Liu M, Chen X, Tang X, Jiao H, Pang D, Bethesda Site-specific Fat-1 knock-in enables significant decrease of n-6PUFAs/n-3PUFAs ratio in pigs. G3 (Bethesda, Md) 2018;8(5):1747–1754. doi: 10.1534/g3.118.200114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liu J, Gaj T, Wallen MC, Barbas CF., 3rd Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids. 2015;4:e232. doi: 10.1038/mtna.2015.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Luo J, Song Z, Yu S, Cui D, Wang B, Ding F, Li S, Dai Y, Li N. Efficient generation of myostatin (MSTN) biallelic mutations in cattle using zinc finger nucleases. PloS One. 2014;9(4):e95225. doi: 10.1371/journal.pone.0095225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ma S, Chang J, Wang X, Liu Y, Zhang J, Lu W, Gao J, Shi R, Zhao P, Xia Q. CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori. Sci Rep. 2014;4:4489. doi: 10.1038/srep04489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct. 2006;1:7. doi: 10.1186/1745-6150-1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mao C, Tao Y. Current progress of genome editing techniques. Chem Life. 2015;35(1):96–104. doi: 10.13488/j.smhx.20150117. [DOI] [Google Scholar]
  34. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 2005;60(2):174–182. doi: 10.1007/s00239-004-0046-3. [DOI] [PubMed] [Google Scholar]
  35. Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science. 2009;326(5959):1501. doi: 10.1126/science.1178817. [DOI] [PubMed] [Google Scholar]
  36. Nerys-Junior A, Braga-Dias LP, Pezzuto P, Cotta-de-Almeida V, Tanuri A. Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene. Genetics Mol Biol. 2018;41(1):167–179. doi: 10.1590/1678-4685-gmb-2017-0065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pavletich NP, Pabo CO. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science. 1991;252(5007):809–817. doi: 10.1126/science.2028256. [DOI] [PubMed] [Google Scholar]
  38. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology. 2005;151(Pt 3):653–663. doi: 10.1099/mic.0.27437-0. [DOI] [PubMed] [Google Scholar]
  39. Proudfoot C, Carlson DF, Huddart R, Long CR, Pryor JH, King TJ, Lillico SG, Mileham AJ, McLaren DG, Whitelaw CB, Fahrenkrug SC. Genome edited sheep and cattle. Transgenic Res. 2015;24(1):147–153. doi: 10.1007/s11248-014-9832-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Qian L, Tang M, Yang J, Wang Q, Cai C, Jiang S, Li H, Jiang K, Gao P, Ma D, Chen Y, An X, Li K, Cui W. Targeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigs. Sci Rep. 2015;5:14435. doi: 10.1038/srep14435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Qiu Z, Liu M, Chen Z, Shao Y, Pan H, Wei G, Yu C, Zhang L, Li X, Wang P, Fan HY, Du B, Liu B, Liu M, Li D. High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases. Nucleic Acids Res. 2013;41(11):e120. doi: 10.1093/nar/gkt258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ricroch AE, Henard-Damave MC. Next biotech plants: new traits, crops, developers and technologies for addressing global challenges. Crit Rev Biotechnol. 2016;36(4):675–690. doi: 10.3109/07388551.2015.1004521. [DOI] [PubMed] [Google Scholar]
  43. Ruan J, Xu J, Chen-Tsai RY, Li K. Genome editing in livestock: are we ready for a revolution in animal breeding industry? Transgenic Res. 2017;26(6):715–726. doi: 10.1007/s11248-017-0049-7. [DOI] [PubMed] [Google Scholar]
  44. Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, Pierick CJ, Hoffman E, Maeder ML, Khayter C, Reyon D, Dobbs D, Langenau DM, Stupar RM, Giraldez AJ, Voytas DF, Peterson RT, Yeh JR, Joung JK. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) Nat Methods. 2011;8(1):67–69. doi: 10.1038/nmeth.1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shukla VK, Doyon Y, Miller JC, DeKelver RC, Moehle EA, Worden SE, Mitchell JC, Arnold NL, Gopalan S, Meng X, Choi VM, Rock JM, Wu YY, Katibah GE, Zhifang G, McCaskill D, Simpson MA, Blakeslee B, Greenwalt SA, Butler HJ, Hinkley SJ, Zhang L, Rebar EJ, Gregory PD, Urnov FD. Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature. 2009;459(7245):437–441. doi: 10.1038/nature07992. [DOI] [PubMed] [Google Scholar]
  46. Soldner F, Laganiere J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011;146(2):318–331. doi: 10.1016/j.cell.2011.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stern A, Keren L, Wurtzel O, Amitai G, Sorek R. Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genetics TIG. 2010;26(8):335–340. doi: 10.1016/j.tig.2010.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sugano SS, Nishihama R, Shirakawa M, Takagi J, Matsuda Y, Ishida S, Shimada T, Hara-Nishimura I, Osakabe K, Kohchi T. Efficient CRISPR/Cas9-based genome editing and its application to conditional genetic analysis in Marchantia polymorpha. bioRxiv. 2018;13(10):e0205117. doi: 10.1371/journal.pone.0205117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sung YH, Jin Y, Kim S, Lee HW. Generation of knockout mice using engineered nucleases. Methods. 2014;69(1):85–93. doi: 10.1016/j.ymeth.2014.02.009. [DOI] [PubMed] [Google Scholar]
  50. Tesson L, Usal C, Menoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L, Gregory PD, Anegon I, Cost GJ. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol. 2011;29(8):695–696. doi: 10.1038/nbt.1940. [DOI] [PubMed] [Google Scholar]
  51. Townsend JA, Wright DA, Winfrey RJ, Fu F, Maeder ML, Joung JK, Voytas DF. High-frequency modification of plant genes using engineered zinc-finger nucleases. Nature. 2009;459(7245):442–445. doi: 10.1038/nature07845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wang X, Cai B, Zhou J, Zhu H, Niu Y, Ma B, Yu H, Lei A, Yan H, Shen Q, Shi L, Zhao X, Hua J, Huang X, Qu L, Chen Y. Correction: disruption of FGF5 in cashmere goats using CRISPR/Cas9 results in more secondary hair follicles and longer fibers. PloS One. 2016;11(11):e0167322. doi: 10.1371/journal.pone.0167322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wang X, Niu Y, Zhou J, Yu H, Kou Q, Lei A, Zhao X, Yan H, Cai B, Shen Q, Zhou S, Zhu H, Zhou G, Niu W, Hua J, Jiang Y, Huang X, Ma B, Chen Y. Multiplex gene editing via CRISPR/Cas9 exhibits desirable muscle hypertrophy without detectable off-target effects in sheep. Sci Rep. 2016;6:32271. doi: 10.1038/srep32271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wei Y, Chesne MT, Terns RM, Terns MP. Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus. Nucleic Acids Res. 2015;43(3):1749–1758. doi: 10.1093/nar/gku1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wright DA, Li T, Yang B, Spalding MH. TALEN-mediated genome editing: prospects and perspectives. Biochem J. 2014;462(1):15–24. doi: 10.1042/bj20140295. [DOI] [PubMed] [Google Scholar]
  56. Wu H, Wang Y, Zhang Y, Yang M, Lv J, Liu J, Zhang Y. TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proc Natl Acad Sci USA. 2015;112(13):E1530–E1539. doi: 10.1073/pnas.1421587112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Xiao A, Hu YY, Wang WY, Yang ZP, Wang ZX, Huang P, Tong XJ, Zhang B, Lin S. Progress in zinc finger nuclease engineering for targeted genome modification. Yi chuan=Hereditas. 2011;33(7):665–683. doi: 10.3724/SP.J.1005.2011.00665. [DOI] [PubMed] [Google Scholar]
  58. Xu L, Yang H, Gao Y, Chen Z, Xie L, Liu Y, Liu Y, Wang X, Li H, Lai W, He Y, Yao A, Ma L, Shao Y, Zhang B, Wang C, Chen H, Deng H. CRISPR/Cas9-mediated CCR5 ablation in human hematopoietic stem/progenitor cells confers HIV-1 resistance in vivo. Mol Ther. 2017;25(8):1782–1789. doi: 10.1016/j.ymthe.2017.04.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Yu S, Luo J, Song Z, Ding F, Dai Y, Li N. Highly efficient modification of beta-lactoglobulin (BLG) gene via zinc-finger nucleases in cattle. Cell Res. 2011;21(11):1638–1640. doi: 10.1038/cr.2011.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yu B, Lu R, Yuan Y, Zhang T, Song S, Qi Z, Shao B, Zhu M, Mi F, Cheng Y. Efficient TALEN-mediated myostatin gene editing in goats. BMC Dev Biol. 2016;16(1):26. doi: 10.1186/s12861-016-0126-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zhang K, Raboanatahiry N, Zhu B, Li M. Progress in genome editing technology and its application in plants. Front Plant Sci. 2017;8:177. doi: 10.3389/fpls.2017.00177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Zhang J, Cui ML, Nie YW, Dai B, Li FR, Liu DJ, Liang H, Cang M. CRISPR/Cas9-mediated specific integration of fat-1 at the goat MSTN locus. FEBS J. 2018;285(15):2828–2839. doi: 10.1111/febs.14520. [DOI] [PubMed] [Google Scholar]
  63. Zhou W, Wan Y, Guo R, Deng M, Deng K, Wang Z, Zhang Y, Wang F. Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9. PloS One. 2017;12(10):e0186056. doi: 10.1371/journal.pone.0186056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from 3 Biotech are provided here courtesy of Springer

RESOURCES